Back to filter
Original filing (PDF)20251015192839NAL0005725569001
ADAMS STREET PARTNERS, LLC
Form 5500
FILING_RECEIVED
ADAMS STREET RSP LP
Employee benefit plan
Active participants
0
Accounts w/ balance
—
Plan assets (EOY)
$679.5M
Net assets (EOY)
$679.4M
How this plan invests
This plan
109 securities
funds · stocks · CUSIPs
Holdings are itemized directly on this plan's Schedule of Assets, below.
Plan health score (directional)
90
/ 100
Grade A
Top-tier plan health
Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.
Compliance & disclosures
100
Concentration risk
100
Total plan cost
65
Vendor stack
100
Participation health
90
Knocking points off
- 23 bps in Schedule C fees — 279% above peer band of 6 bps.
- No active participants reported but plan still holds assets.
Decision-maker contacts
CFO / Head of HR / Benefits Manager — verified email + LinkedIn for ADAMS STREET PARTNERS, LLC.
Plan sponsor
Name
ADAMS STREET PARTNERS, LLC
EIN
37-1831297
Address
ONE NORTH WACKER DRIVE · STE 2700 · CHICAGO, IL · 606062823
Phone
(312) 553-7890
Plan administrator
Same as plan sponsor.
Plan characteristics
Plan number
001
Plan year
2024
Plan year begin
2024-01-01
Tax period
2024-12-31
Filed
2025-10-15
Audit & trust (Schedule H)
Auditor
KPMG LLP
Trustee / custodian
—
Trustee phone
—
Service providers (Schedule C)
3 rowsOther
3| Name | EIN | Location | Relation | Direct comp | Indirect comp |
|---|---|---|---|---|---|
| ADAMS STREET PARTNERS LP | 36-4395128 | — | NONE | $1.3M | — |
| KPMG LLP | 13-5565207 | — | NONE | $186K | — |
| JP MORGAN CHASE BANK | 13-4994650 | — | NONE | $10K | — |
Investments
109 direct securities· $680.7M(100% of reported assets)
| PI | Investment | Type | Shares / units | Cost | Current value | % of plan |
|---|---|---|---|---|---|---|
| Adams Street Venture Innovation Fund LP | — | — | $24.8M | $57.4M | 8.5% | |
| Andreessen Horowitz Fund VI | — | — | $10.0M | $31.8M | 4.7% | |
| Serent Capital III LP | — | — | $7.3M | $26.0M | 3.8% | |
| JPMorgan US Government Money Market Fund | — | — | $25.3M | $25.3M | 3.7% | |
| Adams Street Venture/Growth Fund VI LP | — | — | $16.5M | $25.0M | 3.7% | |
| Oak HC/FT Partners II | — | — | $10.4M | $23.6M | 3.5% | |
| TA XIII-A | — | — | $11.8M | $19.6M | 2.9% | |
| BRV Aster Fund II | — | — | $10.9M | $19.6M | 2.9% | |
| Vitruvian Investment Partnership III LP | — | — | $11.9M | $19.0M | 2.8% | |
| CX Partners Fund 2 | — | — | $11.6M | $18.4M | 2.7% | |
| ACP Investment Fund III | — | — | $10.7M | $18.1M | 2.7% | |
| Index Ventures Growth IV | — | — | $8.8M | $17.8M | 2.6% | |
| Item 4i - Schedule of Assets (Held At End of Year) Subheader Investments Cost Fair Value ABRY Partners IX | — | — | $13.1M | $17.0M | 2.5% | |
| American Industrial Partners Capital Fund VII | — | — | $10.8M | $16.6M | 2.4% | |
| India Life Sciences Fund III, LLC | — | — | $8.9M | $15.7M | 2.3% | |
| TDR Capital IV | — | — | $12.4M | $15.4M | 2.3% | |
| PSC Marlin | — | — | $5.7M | $14.9M | 2.2% | |
| Thoma Bravo XIII | — | — | $8.3M | $13.9M | 2.0% | |
| G Square Capital III | — | — | $12.3M | $13.7M | 2.0% | |
| SK Capital Partners V | — | — | $11.7M | $13.4M | 2.0% | |
| Atlantic Street Capital III | — | — | $8.3M | $13.1M | 1.9% | |
| Waterland Private Equity Fund VII | — | — | $11.2M | $12.7M | 1.9% | |
| Clearview Capital Fund IV | — | — | $11.4M | $12.5M | 1.8% | |
| Energy & Minerals Group Fund IV | — | — | $11.5M | $12.3M | 1.8% | |
| New Mountain Partners V | — | — | $8.2M | $11.8M | 1.7% | |
| New Enterprise Associates 16 | — | — | $9.1M | $11.3M | 1.7% | |
| Source Code Fund III | — | — | $8.5M | $10.9M | 1.6% | |
| HgCapital Mercury 2 | — | — | $2.2M | $10.5M | 1.5% | |
| Silver Lake Partners V | — | — | $7.3M | $10.3M | 1.5% | |
| Industrial Opportunity Partners III | — | — | $7.5M | $10.3M | 1.5% | |
| Accel Growth Fund V | — | — | $7.2M | $10.0M | 1.5% | |
| Pearl Energy Investments II | — | — | $6.0M | $9.4M | 1.4% | |
| Clayton, Dubilier & Rice Fund X | — | — | $6.2M | $9.4M | 1.4% | |
| InvestIndustrial VII | — | — | $5.6M | $9.3M | 1.4% | |
| STG V | — | — | $6.3M | $9.0M | 1.3% | |
| Oakley Capital Private Equity III-B | — | — | $448K | $5.6M | 0.8% | |
| ABS Capital Partners VIII | — | — | $4.0M | $5.4M | 0.8% | |
| Exact Software | — | — | $1.2M | $5.2M | 0.8% | |
| Lyfe Capital Fund II | — | — | $6.2M | $5.1M | 0.7% | |
| Easy Park Holding AS | — | — | $904K | $4.9M | 0.7% | |
| Timezone | — | — | $858K | $4.5M | 0.7% | |
| Ascent Resources, LLC | — | — | $2.5M | $3.9M | 0.6% | |
| Independent Vetcare Limited | — | — | $212K | $3.8M | 0.6% | |
| Siete Family Foods, Inc. | — | — | $1.5M | $3.8M | 0.6% | |
| Enlink Midstream | — | — | $2.6M | $3.7M | 0.5% | |
| Energy & Minerals Group Fund III | — | — | $5.9M | $3.4M | 0.5% | |
| Adams Street RSP LP 2024 Form 5500, Schedule H FEIN 37-1831297, Plan Number 001 Item 4i - Schedule of Assets (Held At End of Year) Subheader Investments Cost Fair Value Pregis Corporation | — | — | $1.7M | $3.4M | 0.5% | |
| PSC III G, LP | — | — | $795K | $2.9M | 0.4% | |
| ABRY Partners VIII | — | — | $6.2M | $2.9M | 0.4% | |
| Accel Leaders Fund II | — | — | $2.3M | $2.8M | 0.4% | |
| Inmar, Inc. | — | — | $1.3M | $2.7M | 0.4% | |
| MYOB Group Limited | — | — | $1.8M | $2.4M | 0.4% | |
| Anaqua, Inc. | — | — | $644K | $2.3M | 0.3% | |
| GFL Environmental | — | — | $402K | $1.9M | 0.3% | |
| Asurion Corporation | — | — | $1.2M | $1.8M | 0.3% | |
| Investindustrial IV Build up | — | — | $2.5M | $1.7M | 0.3% | |
| CIVC Partners Fund V | — | — | $699K | $1.3M | 0.2% | |
| Oak HC/FT Partners | — | — | $859K | $1.3M | 0.2% | |
| World Gym Taiwan | — | — | $1.5M | $1.2M | 0.2% | |
| Southern Cross Latin America Private Equity Fund | — | — | $645K | $1.1M | 0.2% | |
| Blue Water Energy Fund I-A | — | — | $1.5M | $1.1M | 0.2% | |
| Ten-X | — | — | $716K | $1.1M | 0.2% | |
| Eurazeo Capital III | — | — | $1.8M | $1.1M | 0.2% | |
| Behrman Capital VI | — | — | $938K | $1.1M | 0.2% | |
| Phoenix Equity Partners 2016 Fund | — | — | $699K | $827K | 0.1% | |
| Accel London II | — | — | $287K | $820K | 0.1% | |
| Rodan and Fields, LLC | — | — | — | $791K | 0.1% | |
| CellCarta | — | — | $1.8M | $774K | 0.1% | |
| BC European Capital X | — | — | $515K | $703K | 0.1% | |
| Inmar, Inc. | — | — | $317K | $667K | <0.1% | |
| HgCapital 7 D | — | — | $2.0M | $635K | <0.1% | |
| Excelitas 1 | — | — | $243K | $624K | <0.1% | |
| Warburg Pincus XI | — | — | $1.6M | $607K | <0.1% | |
| Warburg Pincus Private Equity XI | — | — | $1.0M | $602K | <0.1% | |
| ABRY Partners VII | — | — | $2.0M | $565K | <0.1% | |
| Adams Street RSP LP 2024 Form 5500, Schedule H FEIN 37-1831297, Plan Number 001 Item 4i - Schedule of Assets (Held At End of Year) Subheader Investments Cost Fair Value ACP Investment Fund | — | — | $5.4M | $552K | <0.1% | |
| ABS Capital Partners VII | — | — | $3.0M | $449K | <0.1% | |
| ACP Investment Fund II | — | — | $767K | $430K | <0.1% | |
| Capital Economics Research Ltd | — | — | $272K | $415K | <0.1% | |
| Capital Economics Research Ltd | — | — | $223K | $413K | <0.1% | |
| ABRY Senior Equity IV | — | — | $1.4M | $387K | <0.1% | |
| FTV IV 0 | — | — | — | $285K | <0.1% | |
| Energy & Minerals Group Fund II | — | — | $296K | $281K | <0.1% | |
| DBAG Expansion Capital Fund International GmbH | — | — | $659K | $250K | <0.1% | |
| Blackstone Capital Partners V | — | — | — | $233K | <0.1% | |
| Prairie V 0 | — | — | — | $202K | <0.1% | |
| DBAG Expansion International First New Vintage | — | — | $80K | $141K | <0.1% | |
| Comprehensive Pharmacy Services, Inc. | — | — | $45K | $137K | <0.1% | |
| Welsh, Carson, Anderson & Stowe XII | — | — | $129K | $130K | <0.1% | |
| BioAgilytix | — | — | $323K | $120K | <0.1% | |
| Industrial Opportunity II | — | — | $2.0M | $112K | <0.1% | |
| Madison Dearborn Capital Partners VI | — | — | — | $106K | <0.1% | |
| CIVC Partners Fund IV | — | — | $1.7M | $104K | <0.1% | |
| Warburg Pincus Private Equity X | — | — | $848K | $87K | <0.1% | |
| FTVentures III | — | — | $124K | $80K | <0.1% | |
| Rimini Street, Inc. - Invested through Adams Street Growth | — | — | $133K | $52K | <0.1% | |
| Mankind Pharma Ltd. | — | — | — | $35K | <0.1% | |
| Summit Partners Private Equity Fund VII-B | — | — | $182K | $30K | <0.1% | |
| Sequel | — | — | $1.3M | $25K | <0.1% | |
| Accel Europe | — | — | $96K | $20K | <0.1% | |
| Capital Economics Research Ltd | — | — | $10K | $16K | <0.1% | |
| Luxe II | — | — | $9K | $15K | <0.1% | |
| Schülerhilfe 0 | — | — | — | $12K | <0.1% | |
| Jaggaer | — | — | — | $9K | <0.1% | |
| ABRY Advanced Securities Fund III | — | — | $1.9M | $7K | <0.1% | |
| Welsh, Carson, Anderson & Stowe XI | — | — | $777K | $6K | <0.1% | |
| Clearview Capital II 0 | — | — | — | $5K | <0.1% | |
| Career Partners GmbH 0 | — | — | — | $3K | <0.1% | |
| Blackstone Capital Partners IV | — | — | $64K | $1K | <0.1% |
